
|Videos|March 16, 2022
Dr. Humphrey discusses takeaways from NY GU 2022 in RCC/bladder cancer
Author(s)Urology Times staff
“One of the reasons I so enjoy this conference is the multidisciplinary nature,” says Peter A. Humphrey, MD, PhD.
Advertisement
In this video, Peter A. Humphrey, MD, PhD, provides an overview of some important takeaways in bladder and kidney cancer that were discussed at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Humphrey is a professor of pathology and the director of genitourinary pathology at the Yale University School of Medicine in New Haven, Connecticut.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Sarah Azari, MD, on early sexual health education for women with bladder cancer
4
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
5






